Bayer's blood thinner fails Eliquis test, sinking phase 3 trial and denting $5B sales forecast
AZ launches digital clinical trials business
Is Novavax, the latecomer COVID vaccine, worth the wait?
MSLs rejoice, overtaking sales reps as pharma’s prime information conveyors
*please scroll down for all the latest news*
